Demonstrating non-inferiority in clinical trials is usually more challenging than showing superiority. In multiple sclerosis (MS), non-inferiority trials are rarely designed since they would require prohibitive sample sizes. In this brief report, the reasons why non-inferiority trials are usually larger than superiority trials is explored
Why non-inferiority is more challenging than superiority?
SORMANI, MARIA PIA
2017
Abstract
Demonstrating non-inferiority in clinical trials is usually more challenging than showing superiority. In multiple sclerosis (MS), non-inferiority trials are rarely designed since they would require prohibitive sample sizes. In this brief report, the reasons why non-inferiority trials are usually larger than superiority trials is explored
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
sormani2017 why.pdf
accesso chiuso
Tipologia:
Documento in versione editoriale
Dimensione
400.48 kB
Formato
Adobe PDF
|
400.48 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
